ADMA BIOLOGICS INC stock forecast: down to 1.34 USD ADMA stock price prognosis
Forecast for Thu 27 Jan 2022 price
ADMA BIOLOGICS INC stock price forecast for further price development down to -1.41% (time horizon: 1 day) and price target of 1.34 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) ADMA BIOLOGICS INC share price prediction for 2022-01-27 with daily closed price projections
On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.
The forecast (dashed curve) of the share price performance is based on historical data.
Our forecast model is based on mathematical, statistical methods.
The website offers price forecasts and analysis tools for equities and other securities,
which are exclusively based on the prices of these securities in the past.
Information about these prices is provided to us by third parties. Although we believe,
If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and
correct sequencing of this information.
We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider
any financial data or other data of such issuers with the exception of the past prices of the securities.
Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or
that may be relevant for future security price flows. Investments require additional considerations.
Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor
or the tax implications an investment may have for the investor. Although we believe that
our mathematical models are a tool to try to explore the possibility for future price development
with the help of past performance, such developments are subject to a multitude of different influences.
and therefore not really predictable.
We cannot guarantee the success of any investment you make based on the information published here.
This website is for information purposes only. All information and data on this website cannot be guaranteed
to be accurate,
accuracy, completeness and appropriateness - neither explicit nor implicit.
Summerized Form 10-K with GPT-2
These PIs are a group of genetic disorders. 2019 using a process known as fractionation. Commercial sales of ASCENIV commenced in October of 2019. The safety profile of ASCENIV is comparable to that of other immunoglobulins. The mean fold change for placebo treated patients was 1.42 (95% CI 0.64, 3.17). These purification processes have the potential to reduce the viral load. 183;Certain Phase III clinical trials are referred to as pivotal trials. The FDA and the sponsor must reach agreement on the PSP. Such post-approval studies are typically referred to as Phase IV studies. Coverage policies and third-party reimbursement rates may change at any time. The Florida telephone number is (561) 989-5800. Such filings are also available to the public on the SEC\'s website at www.sec.gov. 183;Our auditor's report contains a going concern statement. These losses are expected to continue for an extended period of time. We may not be able to generate these revenues or achieve profitability in the future. FDA's guidance is continually evolving. The COVID-19 pandemic may also result in changes in laws and regulations. The ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change. If we are unable to successfully manage our growth, our business may be harmed. Furthermore, if such activities are prohibited, it may harm demand for our products. These fees may adversely affect our future financial prospects and performance. Many of these factors are beyond our control. As a result, an investor might find it more difficult to dispose of our common stock.
Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.
Meta analyst score 38.87/100
Not in ideal financial position.
Historical view, profit is growing.
Company revenue is not growing faster compared with the
Stock price is under book price value.
Institutional ownership list is based on filling form information
ADMA BIOLOGICS INC Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.
On-Balance Volume information for ADMA BIOLOGICS INC. On-Balance Volume information can be an indicator for bullish or bearish outcome.
Accumulation / Distribution (A/D) indicator information for ADMA BIOLOGICS INC. The indicator identify divergences between price and volume flow.
Aroon Oscillator information for ADMA BIOLOGICS INC. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.
Average Directional Index (ADX) information for ADMA BIOLOGICS INC. The index can be used to identify the strengh of a trend.
Moving Average Convergence Divergence (MACD) for ADMA BIOLOGICS INC. The indicator helps to predict trend direction and the momentum of the trend.
Stochastic Oscillator as momentum indicator for ADMA BIOLOGICS INC. The indicator is useful for identifying overbought and oversold levels.
Relative Strength Index (RSI) for ADMA BIOLOGICS INC. RSI is a momentum oscillator that measures the speed and change of price development.
The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period.
Primary usage of the indicator is to identify overbought or oversold signals.
When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30
Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio